Ratnakar Securities Pvt. Ltd.

RAINBOW CHILDREN'S MEDICARE LTD.

NSE : RAINBOWBSE : 543524ISIN CODE : INE961O01016Industry : Hospital & Healthcare ServicesHouse : Private

BSE1390.10-27.1 (-1.91 %)

PREV CLOSE ( ) 1417.20

OPEN PRICE ( ) 1431.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 36224

TODAY'S LOW / HIGH ( )1343.95 1431.95

52 WK LOW / HIGH ( )1079.25 1708.5

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-08 1998

Management Info

Ramesh Kancharla - Chairman Ramesh Kancharla - Managing Director

Registered Office

Address 8-2-120/103/1,Survey No. 403, Road No. 2,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040-49692218

Email info@rainbowhospitals.in

Website www.rainbowhospitals.in

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

06Mar Update On Purchase Of Land Parcels Lo
Update on Purchase of Land Parcels Located in Sector 44 & Sector 56 of G..

04Mar Rainbow Childrenâ€™s Medicare informs
Rainbow Childrenâ€™s Medicare has informed that it enclosed a copies of..

03Mar Rainbow Children's Medicare receives a
Rainbow Children's Medicare has received the necessary approvals from Ha..

10Feb Rainbow Children's Medicare reports 10
Rainbow Children's Medicare has reported results for third quarter ended..

10Feb Rainbow Children's Medicare declines d
Rainbow Children's Medicare is currently trading at Rs. 1344.30, down by..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	545.4	2375.85
Gross Profit	747.46	3220.83
Operating Profit	1247.09	5234.25
Net Sales	3539.95	14545.07

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 4498.50 (0.55%)	M.Cap ( in Cr)2114.30
Narayana Hrudayalay (BSE) 1835.45 (1.20%)	M.Cap ( in Cr)37509.40
Krishna Inst.Medi (BSE) 671.45 (3.05%)	M.Cap ( in Cr)26867.33
Dr. Lal Pathlabs (BSE) 2977.75 (0.58%)	M.Cap ( in Cr)24946.25
Choksi Lab (BSE) 175.60 (9.78%)	M.Cap ( in Cr)122.31

Shareholding Pattern

	PROMOTERS	49.85%
	MUTUAL FUNDS/UTI	11.47%
	NON-INSTITUTION	11.14%
	FI/BANKS/INSURANCE	1.71%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
SBI LT Advantage Fu...	3.07
Motilal Oswal Small...	2.70
HSBC Focused Fund-Reg(G)	2.70
DSP India T.I.G.E.R...	2.69
HSBC Consumption Fu...	2.55
SBI Healthcare Opp ...	2.48

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

RAINBOW CHILDREN'S MEDICARE LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES